Reimagining medicine: Novartis’s breakthrough therapies
Listen now
Description
With a market cap of $200bn, Novartis is one of the largest pharmaceutical companies in the world and a leader in developing trusted innovative therapies to improve and prolong people’s lives. Under the visionary leadership of CEO Vasant Narasimhan, Novartis has achieved extraordinary breakthroughs in gene, cell and other transformative therapies. Vasant Narasimhan, who rarely participates in podcast interviews, discusses these key developments, and their implications, with Magellan’s Chairman and Chief Investment Officer, Hamish Douglass
More Episodes
The long term regular and reliable returns from the infrastructure sector present an overwhelming opportunity. Infrastructure investing may initially seem intimidating to investors due to the substantial capital expenditures that companies require upfront. However, the long term regular and...
Published 05/28/24
Published 05/28/24
Markets were taught a lesson in the turn-of-the-century’s dot-com bubble. Over excitement and massive investment in companies that hardly really existed, let alone made worthwhile returns, resulted in a traumatic correction. But is it happening again? With the high-profile technology companies —...
Published 04/30/24
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
